LEI NIE to Neoplasm Recurrence, Local
This is a "connection" page, showing publications LEI NIE has written about Neoplasm Recurrence, Local.
Connection Strength
0.090
-
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and S?zary Syndrome. Clin Cancer Res. 2019 12 15; 25(24):7275-7280.
Score: 0.046
-
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma. Haematologica. 2023 06 01; 108(6):1616-1627.
Score: 0.015
-
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma. Mol Cancer. 2022 09 26; 21(1):185.
Score: 0.014
-
Targeting Fc?RIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma. J Hematol Oncol. 2022 04 11; 15(1):42.
Score: 0.014